Press releases | WebDisclosure

Basculer en Français

9743	Companies
194599	Keywords
125697	Articles
103506	Press releases

Home
Press releases

PRESS RELEASE

published on 04/22/2025 at 22:05, 9 months 3 days ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle et se rapproche d'étapes clés créatrices de valeur en 2025. Essais cliniques ABTECT de phase 3 en progression

Abivax Étapes Clés Assemblée Générale Annuelle Phase 3 ABTECT
PRESS RELEASE

published on 04/22/2025 at 22:05, 9 months 3 days ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 9 months 3 days ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax nomme le Dr Dominik Höchli au Conseil d’administration pour renforcer son expertise en immunologie avant la publication des données clés de l’étude de phase 3 dans la rectocolite hémorragique en 2025

Abivax Conseil D'administration Rectocolite Hémorragique Immunologie Dr Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:00, 9 months 3 days ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3

Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE

published on 04/22/2025 at 22:00, 9 months 3 days ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
PRESS RELEASE

published on 04/22/2025 at 21:51, 9 months 3 days ago

EQS-Adhoc: PIERER Mobility AG: Postponement of the Annual Financial Report 2024, announcement of publishing additional preliminary figures for the 2024 financial year, modification to the agenda of the GM
PIERER Mobility AG postpones annual financial report for 2024, provides additional preliminary figures, and makes modifications to upcoming General Meeting agenda

Restructuring PIERER Mobility AG General Meeting Preliminary Figures Postponement
PRESS RELEASE

published on 04/22/2025 at 19:55, 9 months 3 days ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
Mangoceuticals Inc. introduces innovative men's health products through MangoRx, revolutionizing ED, testosterone therapy, hair restoration, and weight loss. CEO Jacob Cohen discusses the groundbreaking approach in an exclusive interview with Hawk Point Media

Mangoceuticals Inc. MangoRx Men's Health Products Jacob Cohen Hawk Point Media
PRESS RELEASE

published on 04/22/2025 at 19:52, 9 months 3 days ago

Invitation: Straumann Group 2025 first-quarter results webcast
Straumann Group invites investors to webcast for review of 2025 first-quarter results on April 30, 2025, 10:30 - 11:30 a.m. CEST. Presentation and Q&A in English

Investors Webcast Straumann Group Financial Analysts 2025 First-quarter Results
PRESS RELEASE

published on 04/22/2025 at 19:45, 9 months 3 days ago

Annual General Meeting 2025
Bystronic AG shareholders approve dividends and reelect Board of Directors members at Annual General Meeting 2025 in Zurich

Board Of Directors Annual General Meeting Shareholders Bystronic AG Dividends
PRESS RELEASE

published on 04/22/2025 at 19:45, 9 months 3 days ago

NewsOut Launches Weekly Video Press Release Coverage on Tesla, Amazon, Apple, NVIDIA, and Microsoft
NewsOut to feature weekly video coverage of top companies like Tesla, Amazon, Apple, NVIDIA, and Microsoft. Segments include professional journalism, data visualization, and cross-platform distribution

Amazon Tesla Video Coverage NewsOut Apple

Accesswire

Published on 01/26/2026 at 15:42, 2 hours 13 minutes ago

Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 15:30, 2 hours 25 minutes ago

Silver Spruce Announces Director and Officer Resignation
Published on 01/26/2026 at 14:00, 3 hours 55 minutes ago

Rare Earth Targets Refined as IP, MT, Radiometric and Geological Data Converge at Colosseum Project
Published on 01/26/2026 at 14:00, 3 hours 55 minutes ago

Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers
Published on 01/26/2026 at 13:45, 4 hours 10 minutes ago

Quartz Announces Significant Induced Polarization Survey Results for Maestro Gold-Silver Project, British Columbia

View all ACCESSWIRE

EQS Group

Published on 01/26/2026 at 17:45, 10 minutes ago

Dr. Christian Schlögel nominated as new member of the Board of Directors
Published on 01/26/2026 at 17:40, 15 minutes ago

VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Published on 01/26/2026 at 17:40, 15 minutes ago

VALBIOTIS SA: Valbiotis lance un avantage commercial exclusif pour ses actionnaires : 20% de réduction sur ses gammes ValbiotisPRO® et ValbiotisPLUS®
Published on 01/26/2026 at 17:35, 20 minutes ago

Issue of Equity
Published on 01/26/2026 at 16:55, 1 hour ago

# UnionPay at Davos 2026: Showcasing China's Economic Resilience for a New Global Development Blueprint

Les Echos

Published on 01/26/2026 at 17:45, 10 minutes ago

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 10 minutes ago

Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Published on 01/26/2026 at 17:45, 10 minutes ago

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 10 minutes ago

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:35, 20 minutes ago

Disclosure of transactions in own shares from January 19 to January 23, 2026

View all LES ECHOS COMFI WIRE